CEUFAST COURSE

Postpartum Hemorrhage

Contact Hour(s): 2 Contact Hours including 2 Advanced Pharmacology HoursAuthor:Kelly LaMonica, DNP(c), MSN, RNC-OB, EFMThis peer-reviewed course is applicable for the following professions: Advanced Practice Registered Nurse (APRN), Cert...

Course Summary

Contact Hour(s): 

2 Contact Hours including 2 Advanced Pharmacology Hours

Author:

Kelly LaMonica, DNP(c), MSN, RNC-OB, EFM

This peer-reviewed course is applicable for the following professions: 

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:  

 Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; ; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; 

Course Description:

This course discusses risk factors, causes, assessment, and evidence-based treatment for postpartum hemorrhage. It also will discuss necessary follow-up care and care that is necessary for family members and caregivers of patients with postpartum hemorrhage.

Outcomes:

≥ 92% of participants will know how to recognize and respond to a postpartum hemorrhage.

Objectives:

After completing this continuing education course, the participant will be able to:

  1. Define postpartum hemorrhage.
  2. List the risk factors for postpartum hemorrhage.
  3. Assess for postpartum hemorrhage risk.
  4. Interpret the methods to identify postpartum hemorrhage.
  5. Identify how to care for women with postpartum hemorrhage.
  6. Explain the medications used to treat postpartum hemorrhage.
  7. Determine how to provide care for family members and caregivers following a postpartum hemorrhage.
  8. Describe the necessary follow-up care that women with postpartum hemorrhage require.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.